Literature DB >> 11158156

Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.

S Watarai1, K Yokota, T Kishimoto, T Kanadani, K Taketa, K Oguma.   

Abstract

The relationship between differential susceptibility to hemolytic-uremic syndrome (HUS) and levels of globotriaosylceramide (Gb3) in serum was studied in patients infected with verotoxin-producing Escherichia coli (VTEC). The serum Gb3 levels in patients with HUS were lower than these in diarrheal patients without subsequent HUS or in patients without clinical symptoms, indicating that individuals with a lower content of serum Gb3 show a higher incidence of HUS following VTEC infection.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11158156      PMCID： PMC87825          DOI： 10.1128/JCM.39.2.798-800.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Carbohydrates in protein. 4. The determination of mannose in hen's-egg albumin by radioisotope dilution.

Authors:  C FRANCOIS; R D MARSHALL; A NEUBERGER
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

2.  Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.

Authors:  A Cohen; G E Hannigan; B R Williams; C A Lingwood
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

Review 3.  Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome.

Authors:  T G Cleary
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

4.  Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.

Authors:  M Bitzan; M Klemt; R Steffens; D E Müller-Wiefel
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

5.  Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias.

Authors:  G Dawson; A W Kruski; A M Scanu
Journal:  J Lipid Res       Date:  1976-03       Impact factor: 5.922

6.  Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

Authors:  R W Ledeen; R K Yu; L F Eng
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

7.  Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.

Authors:  P C Rowe; E Orrbine; G A Wells; P N McLaine
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

8.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

9.  Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in rats.

Authors:  C Dumontet; A Rebbaa; J Portoukalian
Journal:  Biochem Biophys Res Commun       Date:  1992-12-30       Impact factor: 3.575

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226
View more
  2 in total

1.  Differential susceptibility epidemic models.

Authors:  James M Hyman; Jia Li
Journal:  J Math Biol       Date:  2004-12-20       Impact factor: 2.164

Review 2.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.